These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3088326)

  • 41. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
    SILBERMANSCHWARTZMAN J
    An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
    [No Abstract]   [Full Text] [Related]  

  • 42. [Leucinose. II. Study of heterozygotes].
    Fontaine G; Dautrevaux M; Farriaux JP; Biserte G
    Lille Med; 1967 Apr; 12(4):480-3. PubMed ID: 5619112
    [No Abstract]   [Full Text] [Related]  

  • 43. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Latest data on chemical properties and the physiological role of thiamine and its phosphoric esters].
    Tettamanti G
    Minerva Dietol Gastroenterol; 1985; 31(2):75-94. PubMed ID: 3897910
    [No Abstract]   [Full Text] [Related]  

  • 45. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ["Atypical" metabolic forms of phenylketonuria (PKU) and leucinosis detected in newborn infants].
    Tănase I; Ciortoloman H; Popescu M; Grigorescu G; Ankăr V
    Physiologie; 1977; 14(4):257-61. PubMed ID: 413127
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevated excretion of N-acetylated branched-chain amino acids in maple syrup urine disease.
    Lehnert W; Werle E
    Clin Chim Acta; 1988 Feb; 172(1):123-6. PubMed ID: 3359650
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of alpha-keto acids as silylated oximes in urine and serum by combined gas chromatography-mass spectrometry.
    Sternowsky HJ; Roboz J; Hutterer F; Gaull G
    Clin Chim Acta; 1973 Sep; 47(3):371-9. PubMed ID: 4795614
    [No Abstract]   [Full Text] [Related]  

  • 49. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

  • 50. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WESTALL RG
    Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
    [No Abstract]   [Full Text] [Related]  

  • 51. Ketotic hypoglycaemia associated with transient branched-chain aminoacidemia.
    Hambraeus L; Westphal O; Hagberg B
    Acta Paediatr Scand; 1972 Jan; 61(1):81-9. PubMed ID: 5018580
    [No Abstract]   [Full Text] [Related]  

  • 52. FAMILY SCREENING STUDIES IN MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WOODY NC; HARRIS JA
    J Pediatr; 1965 Jun; 66():1042-8. PubMed ID: 14288457
    [No Abstract]   [Full Text] [Related]  

  • 53. Dietary treatment of maple sirup urine disease (branched-chain ketoaciduria).
    Noel MB; Stanley PB; Girz JC; Allen RJ
    J Am Diet Assoc; 1976 Jul; 69(1):62-8. PubMed ID: 932376
    [No Abstract]   [Full Text] [Related]  

  • 54. A variant form of branched-chain keto aciduria.
    van der Horst JL; Wadman SK
    Acta Paediatr Scand; 1971 Sep; 60(5):594-9. PubMed ID: 5125167
    [No Abstract]   [Full Text] [Related]  

  • 55. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 57. [Vitamin B1 dependency].
    Kuroda Y; Naito E
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):225-8. PubMed ID: 9645049
    [No Abstract]   [Full Text] [Related]  

  • 58. Maple syrup urine disease in Indian baby: branched chain amino and ketoaciduria.
    Dastur DK; Manghani DK; Joshi MK; Adavi SV
    Indian J Med Res; 1966 Oct; 54(10):915-22. PubMed ID: 5976996
    [No Abstract]   [Full Text] [Related]  

  • 59. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
    Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
    Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
    [No Abstract]   [Full Text] [Related]  

  • 60. Intermittent maple syrup urine disease: a case report.
    Ghodsi A; Ajudani TS; Gharavi M; Hatefi GV
    S Afr Med J; 1977 May; 51(21):758-9. PubMed ID: 877799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.